Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Amanat Acquisition Corp. (AMAN)

Amanat signs $200 million business combination with Corxel Pharmaceuticals

Neutral Impact 5 of 5 m&a Written later

Amanat Acquisition Corp, a blank check company listed on Nasdaq as AMAN, entered into a Business Combination Agreement on October 25, 2026 with Corxel Pharmaceuticals, Inc. The deal implies a Corxel equity value of $200,000,000 and would take Corxel public through a merger after AMAN moves from the Cayman Islands to Delaware. The transaction is expected to close in the first half of 2027, subject to approval by AMAN shareholders, who may also redeem their shares for cash from the trust account.

Key points

  • Agreement dated October 25, 2026; closing expected in the first half of 2027, subject to AMAN shareholder approval, Corxel sole stockholder approval and HSR Act clearance.
  • Corxel equity has an implied value of $200,000,000, with Corxel shares converted into New Corxel Common Stock.
  • AMAN Class A shareholders may redeem shares for cash from the trust account; the press release cites approximately $75 million in trust.
  • A concurrent PIPE is expected to bring approximately $300 million, with total expected gross proceeds of about $377 million assuming no redemptions.

The filing

CompanyAmanat Acquisition Corp. (AMAN)
Form8-K, current report
Filed with the SECOct 26, 2026, 6:13 AM ET
Accession number0001213900-26-112236

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.